Research Article
Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis
Figure 1
The expression of CIP2A in EGJA. (a) Hematoxylin-eosin (HE, upper) and immunohistochemistry (IHC, lower) staining of paracancer (left) and esophagogastric junction adenocarcinoma (EGJA, right). (b) Immunoreactivity score (IRS) comparison of CIP2A between paracancer and EGJA (Wilcoxon’s test, ). (c) Expression percentage comparison of CIP2A between paracancer and EGJA (Fisher’s exact test, ).
(a) |
(b) |
(c) |